Items where Author is "Lucia, MB"
Up a level |
Journal article
RUTELLA, S., BONANNO, G., PROCOLI, A., MARIOTTI, A., LUCIA, M.B., CONTEMI, A.M., CAUDA, R., FIANCHI, L., SCAMBIA, G., PAGANO, L. and LEONE, G., 2006. Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells. Experimental Hematology, 34 (1), pp. 54-65. ISSN 0301-472X
LUCIA, M.B., SAVARINO, A., STRAFACE, E., GOLOTTA, C., RASTRELLI, E., MATARRESE, P., RUTELLA, S., MALORNI, W. and CAUDA, R., 2005. Role of lymphocyte multidrug resistance protein 1 in HIV infection: expression, function, and consequences of inhibition. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 40 (3), pp. 257-266. ISSN 1525-4135
LUCIA, M.B., GOLOTTA, C., RUTELLA, S., RASTRELLI, E., SAVARINO, A. and CAUDA, R., 2005. Atazanavir inhibits P-Glycoprotein and multidrug resistance-associated protein efflux activity. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 39 (5), pp. 635-637. ISSN 1525-4135
SAVARINO, A., LUCIA, M.B., RASTRELLI, E., RUTELLA, S., GOLOTTA, C., MORRA, E., TAMBURRINI, E., PERNO, C.F., BOELAERT, J.R., SPERBER, K. and CAUDA, R., 2004. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 35 (3), pp. 223-232. ISSN 1525-4135
LUCIA, M.B., RUTELLA, S., LEONE, G., LAROCCA, L.M., VELLA, S. and CAUDA, R., 2002. In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 30 (4), pp. 369-378. ISSN 1525-4135
LUCIA, M.B., RUTELLA, S., GOLOTTA, C., LEONE, G. and CAUDA, R., 2002. Differential induction of P-glycoprotein and MRP by rifamycins in T lymphocytes from HIV-1/tuberculosis co-infected patients. AIDS, 16 (11), pp. 1563-1565. ISSN 0269-9370
LUCIA, M.B., RUTELLA, S., LEONE, G. and CAUDA, R., 2001. HIV protease inhibitors reduce IL-2 release from normal human phytohaemagglutinin-activated T cells. AIDS, 15 (17), pp. 2339-2341. ISSN 0269-9370
LUCIA, M.B., RUTELLA, S., LEONE, G., VELLA, S. and CAUDA, R., 2001. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART. JAIDS, 27 (4), pp. 321-330. ISSN 1525-4135
LUCIA, M.B., BUONFIGLIO, D., BOTTAREL, F., BENSI, T., RUTELLA, S., RUMI, C., ORTONA, L., JANEWAY, C.A., CAUDA, R. and DIANZANI, U., 2000. Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: correlation with disease status. AIDS Research and Human Retroviruses, 16 (6), pp. 549-557. ISSN 0889-2229
CAUDA, R., LUCIA, M.B., MARASCA, G., RUTELLA, S., PETRUCCI, M.T., VERDE, G. and GASTALDI, R., 1999. Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. European Journal of Haematology, 63 (2), pp. 134-135. ISSN 0902-4441
RUTELLA, S., RUMI, C., LUCIA, M.B., SICA, S., CAUDA, R. and LEONE, G., 1998. Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness. Experimental Hematology, 26 (11), pp. 1024-1033. ISSN 0301-472X
RUTELLA, S., RUMI, C., LUCIA, M.B., ETUK, B., CAUDA, R. and LEONE, G., 1998. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens. Immunology Letters, 60 (1), pp. 51-55. ISSN 0165-2478